Last year at the Pharma Compliance Europe 2014 event, Karolina Czernicka-Kuhl, Novo Nordisk, Head of Legal and Compliand Europe East, gave the presentation "Developing clear and structured monitoring strategies that minimise risks and optimise compliance success rates."
Karolina Czernicka-Kuhl outlines in her presentation:
What should be monitored?
How to monitor (who should monitor)?
Benefits and costs
Remember my details
Privacy statement »
Manage your email preferences »
You will be emailed the document as an attachment (265Kb in size)